PIK3CA and cancer: Here, as shown in Figure1, we demonstrated the combination of aspirin and ABT-737 showed synergistic anti-cancer effects on both PIK3CA wild-type cell lines (A549, H1299, HT-29 and HO-8910) and PIK3CA mutation cell line (HCT-116) in vitro.